Kanāda - angļu - Health Canada

taro pharmaceuticals inc - ciprofloxacin (ciprofloxacin hydrochloride); dexamethasone - suspension - 0.3%; 0.1% - ciprofloxacin (ciprofloxacin hydrochloride) 0.3%; dexamethasone 0.1% - antibacterials

Lielbritānija - angļu - MHRA (Medicines & Healthcare Products Regulatory Agency)

consilient health ltd - dexamethasone; ciprofloxacin hydrochloride - ear drops - 1mg/1ml ; 3mg/1ml

Lielbritānija - angļu - MHRA (Medicines & Healthcare Products Regulatory Agency)

a a h pharmaceuticals ltd - dexamethasone; ciprofloxacin hydrochloride - ear drops - 1mg/1ml ; 3mg/1ml

Lielbritānija - angļu - MHRA (Medicines & Healthcare Products Regulatory Agency)

cst pharma ltd - dexamethasone; ciprofloxacin hydrochloride - ear drops - 1mg/1ml ; 3mg/1ml

Amerikas Savienotās Valstis - angļu - NLM (National Library of Medicine)

sun pharmaceutical industries, inc. - ciprofloxacin hydrochloride (unii: 4ba73m5e37) (ciprofloxacin - unii:5e8k9i0o4u), dexamethasone (unii: 7s5i7g3jql) (dexamethasone - unii:7s5i7g3jql) - ciprofloxacin and dexamethasone otic suspension usp is indicated for the treatment of infections caused by susceptible isolates of the designated microorganisms in the specific conditions listed below: - acute otitis externa (aoe) in pediatric (age 6 months and older), adult and elderly patients due to staphylococcus aureus and pseudomonas aeruginosa . - ciprofloxacin and dexamethasone otic suspension is contraindicated in patients with a history of hypersensitivity to ciprofloxacin, to other quinolones, or to any of the components in this medication. - use of this product is contraindicated in viral infections of the external canal, including herpes simplex infections and fungal otic infections. risk summary there are no available data on ciprofloxacin and dexamethasone otic suspension use in pregnant women to evaluate for a drug-associated risk of major birth defects, miscarriage or adverse maternal or fetal outcomes. because of the minimal systemic absorption of ciprofloxacin and dexamethasone following t

Īrija - angļu - HPRA (Health Products Regulatory Authority)

noridem enterprises limited - dexamethasone sodium phosphate - solution for injection - 4 milligram(s)/millilitre - dexamethasone

Īrija - angļu - HPRA (Health Products Regulatory Authority)

as kalceks - dexamethasone sodium phosphate - solution for injection/infusion - dexamethasone

Īrija - angļu - HPRA (Health Products Regulatory Authority)

fresenius kabi deutschland gmbh - dexamethasone sodium phosphate - solution for injection - dexamethasone

Kanāda - angļu - Health Canada

sandoz canada incorporated - ciprofloxacin (ciprofloxacin hydrochloride); dexamethasone - suspension - 0.3%; 0.1% - ciprofloxacin (ciprofloxacin hydrochloride) 0.3%; dexamethasone 0.1% - antibacterials

Amerikas Savienotās Valstis - angļu - NLM (National Library of Medicine)

alcon laboratories, inc. - ciprofloxacin hydrochloride (unii: 4ba73m5e37) (ciprofloxacin - unii:5e8k9i0o4u), dexamethasone (unii: 7s5i7g3jql) (dexamethasone - unii:7s5i7g3jql) - ciprofloxacin 3 mg in 1 ml - ciprodex is indicated for the treatment of infections caused by susceptible isolates of the designated microorganisms in the specific conditions listed below: acute otitis media (aom) in pediatric patients (age 6 months and older) with tympanostomy tubes due to staphylococcus aureus , streptococcus pneumoniae , haemophilus influenzae , moraxella catarrhalis , and pseudomonas aeruginosa . acute otitis externa (aoe) in pediatric (age 6 months and older), adult and elderly patients due to staphylococcus aureus and pseudomonas aeruginosa . - ciprodex is contraindicated in patients with a history of hypersensitivity to ciprofloxacin, to other quinolones, or to any of the components in this medication. - use of this product is contraindicated in viral infections of the external canal, including herpes simplex infections and fungal otic infections. teratogenic effects. pregnancy category c: no adequate and well controlled studies with ciprodex have been performed in pregnant women. caution should be exercised when